fbpx
close read more
  • Oncology
  • Cardiometabolism
  • Neuroscience
  • immuno-inflammation

Phase 1

Haematological malignancies

Mcl1 inhibitor

Haematological malignancies

Bcl2 inhibitor

Haematological malignancies

DHODH inhibitor

Solid tumors

Anti CD73

Solid tumors

MAT2A inhibitor

Solid tumors

NKG2A

Solid tumors

PDLx41 BB

Solid tumors

Anti PD1xAnti TIM3

Relapsed or refractory myelodysplastic syndrome (MDS)

Tibsovo® (pre-registration)

Grade 2-3 Gliome, combo

Vorasidenib

Phase 2

Sjögren disease

Anti IL7R

Phase 3

Colorectal cancer, 1st line Combo

Lonsurf®

Colorectal cancer, 3rd line Combo

Lonsurf®

Colorectal cancer

Anti EGFR combo Lonsurf®

Acute myeloid leukemia (AML) IC-ineligible, 1st line

Tibsovo®

Acute myeloid leukemia (AML) IC-eligible, 1st line

Tibsovo®

Low-grade Glioma

Vorasidenib